Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials

This systematic review and meta-analysis on randomized controlled trials (RCTs) evaluated the impact of astaxanthin (AST) supplementation on blood pressure in adults. We conducted a comprehensive search using different electronic databases. Ten RCTs with 493 participants that reported the effect of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elahe Mokhtari, Sahar Rafiei, Nafiseh Shokri-Mashhadi, Parvane Saneei
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/f137e5c75ab441a595840832dfc396c0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f137e5c75ab441a595840832dfc396c0
record_format dspace
spelling oai:doaj.org-article:f137e5c75ab441a595840832dfc396c02021-11-24T04:27:35ZImpact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials1756-464610.1016/j.jff.2021.104860https://doaj.org/article/f137e5c75ab441a595840832dfc396c02021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1756464621005090https://doaj.org/toc/1756-4646This systematic review and meta-analysis on randomized controlled trials (RCTs) evaluated the impact of astaxanthin (AST) supplementation on blood pressure in adults. We conducted a comprehensive search using different electronic databases. Ten RCTs with 493 participants that reported the effect of AST supplementation on blood pressure in adults were included. AST supplementation led to a marginally decline in diastolic blood pressure (DBP) (mean difference (MD) = −1.21; 95 %CI: −2.51, 0.09), but not systolic blood pressure. In patients, AST supplementation reduced DBP by 2.77 mmHg (95 %CI: −4.34, −1.19). Also, assigning ≥ 12 mg of AST to adults resulted in a slight decrease in DBP (MD = −0.89; 95 %CI: −1.82, 0.04). AST supplementation significantly reduced DBP by 2.27 mmHg in participants from Asian countries (95 %CI: −3.71, −0.83). This meta-analysis of RCTs disclosed that AST supplementation could reduce DBP, especially with a dose of ≥ 12 mg/d supplementation, in patient individuals and in participants from Asian countries.Elahe MokhtariSahar RafieiNafiseh Shokri-MashhadiParvane SaneeiElsevierarticleAstaxanthinSystolic blood pressureDiastolic blood pressureRandomized controlled trialsMeta-analysisNutrition. Foods and food supplyTX341-641ENJournal of Functional Foods, Vol 87, Iss , Pp 104860- (2021)
institution DOAJ
collection DOAJ
language EN
topic Astaxanthin
Systolic blood pressure
Diastolic blood pressure
Randomized controlled trials
Meta-analysis
Nutrition. Foods and food supply
TX341-641
spellingShingle Astaxanthin
Systolic blood pressure
Diastolic blood pressure
Randomized controlled trials
Meta-analysis
Nutrition. Foods and food supply
TX341-641
Elahe Mokhtari
Sahar Rafiei
Nafiseh Shokri-Mashhadi
Parvane Saneei
Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
description This systematic review and meta-analysis on randomized controlled trials (RCTs) evaluated the impact of astaxanthin (AST) supplementation on blood pressure in adults. We conducted a comprehensive search using different electronic databases. Ten RCTs with 493 participants that reported the effect of AST supplementation on blood pressure in adults were included. AST supplementation led to a marginally decline in diastolic blood pressure (DBP) (mean difference (MD) = −1.21; 95 %CI: −2.51, 0.09), but not systolic blood pressure. In patients, AST supplementation reduced DBP by 2.77 mmHg (95 %CI: −4.34, −1.19). Also, assigning ≥ 12 mg of AST to adults resulted in a slight decrease in DBP (MD = −0.89; 95 %CI: −1.82, 0.04). AST supplementation significantly reduced DBP by 2.27 mmHg in participants from Asian countries (95 %CI: −3.71, −0.83). This meta-analysis of RCTs disclosed that AST supplementation could reduce DBP, especially with a dose of ≥ 12 mg/d supplementation, in patient individuals and in participants from Asian countries.
format article
author Elahe Mokhtari
Sahar Rafiei
Nafiseh Shokri-Mashhadi
Parvane Saneei
author_facet Elahe Mokhtari
Sahar Rafiei
Nafiseh Shokri-Mashhadi
Parvane Saneei
author_sort Elahe Mokhtari
title Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
title_short Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
title_full Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
title_fullStr Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed Impact of astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
title_sort impact of astaxanthin supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials
publisher Elsevier
publishDate 2021
url https://doaj.org/article/f137e5c75ab441a595840832dfc396c0
work_keys_str_mv AT elahemokhtari impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT saharrafiei impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT nafisehshokrimashhadi impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT parvanesaneei impactofastaxanthinsupplementationonbloodpressureasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
_version_ 1718416011991973888